NASDAQ:RSLS ReShape Lifesciences (RSLS) News Today $0.59 -0.02 (-3.28%) (As of 09/22/2023 ET) Add Compare Share Share Today's Range$0.58▼$0.6650-Day Range$0.59▼$1.5352-Week Range$0.57▼$22.40Volume30,132 shsAverage Volume81,810 shsMarket Capitalization$2.04 millionP/E RatioN/ADividend YieldN/APrice Target$8.00 HeadlinesProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineReShape Lifesciences® Announces Participation in the LD Micro Main Event XVIfinance.yahoo.com - September 22 at 9:59 AMReShape Lifesciences® Significantly Strengthens Patent Portfolio Related to its Obalon® Balloon Systemfinance.yahoo.com - September 19 at 9:55 AMReShape Lifesciences Inc: ReShape Lifesciences Receives NIH SBIR Grant to Further Develop Proprietary Diabetes Bloc-Stim Neuromodulation Devicefinanznachrichten.de - September 14 at 1:04 PMReShape Lifesciences® Receives NIH SBIR Grant to Further Develop Proprietary Diabetes Bloc-Stim Neuromodulation™ Devicefinance.yahoo.com - September 14 at 1:04 PMRSLS - ReShape Lifesciences Inc.uk.finance.yahoo.com - September 13 at 5:01 PMReShape Lifesciences Inc. (NASDAQ:RSLS) Q2 2023 Earnings Call Transcriptinsidermonkey.com - August 9 at 5:15 PMAnalysts Are Bullish on Top Healthcare Stocks: Augmedix (AUGX), ReShape Lifesciences (RSLS)markets.businessinsider.com - August 9 at 8:03 AMQ2 2023 ReShape Lifesciences Inc Earnings Callfinance.yahoo.com - August 8 at 9:57 AMReShape Lifesciences® Reports Second Quarter Ended June 30, 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - August 8 at 9:57 AMReShape Lifesciences® to Announce Financial Results for the Second Quarter Ended June 30, 2023 and Provide Corporate Updatefinance.yahoo.com - August 3 at 5:57 PMReShape Lifesciences Inc: ReShape Lifesciences Signs Preferred Partner Agreement With Hive Medical for Lead Optimization Softwarefinanznachrichten.de - June 29 at 10:00 AMReShape Lifesciences® Signs Preferred Partner Agreement With Hive Medical for Lead Optimization Softwarefinance.yahoo.com - June 29 at 10:00 AMReShape Lifesciences® Presents Data on its Proprietary Diabetes Bloc-Stim Neuromodulation™ Device at the ASMBS 2023 Annual Meetingfinance.yahoo.com - June 28 at 9:14 AMReShape Lifesciences Inc: ReShape Lifesciences Submits FDA PMA Supplement Application for the Next-Generation Lap-Band 2.0finanznachrichten.de - June 27 at 7:41 AMReShape Lifesciences® to Participate in Investor and Industry Conferences in Junefinance.yahoo.com - June 14 at 9:19 AMQ1 2023 ReShape Lifesciences Inc Earnings Callfinance.yahoo.com - May 16 at 8:20 AMReShape Lifesciences® Reports First Quarter Ended March 31, 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - May 15 at 5:18 PMReShape Lifesciences® to Announce Financial Results for the First Quarter Ended March 31, 2023 and Provide Corporate Updatefinance.yahoo.com - May 11 at 12:34 PMReShape Lifesciences(R) to Present Data on its Proprietary Diabetes Bloc-Stim Neuromodulation(TM) Device at the Keystone Symposia on Type 2 Diabetesmarketwatch.com - April 28 at 1:23 AMReShape Lifesciences® Reports Year Ended December 31, 2022 Financial Results and Provides Corporate Updatefinance.yahoo.com - April 25 at 8:43 PMReShape Lifesciences (RSLS) Gets a Buy from Maxim Groupmarkets.businessinsider.com - April 25 at 3:42 PMInvestors Continue Waiting On Sidelines For ReShape Lifesciences Inc. (NASDAQ:RSLS)finance.yahoo.com - April 19 at 3:58 PMReShape Lifesciences gets patent for Obalon balloon systemseekingalpha.com - April 11 at 1:40 PMReshape Lifesciences Stock (NASDAQ:RSLS), Guidance and Forecastbenzinga.com - March 30 at 3:20 PMReShape Lifesciences® To Delay Year Ended December 31, 2022 Earnings Release and Conference Callfinance.yahoo.com - March 29 at 1:00 AMReShape Lifesciences Announces Formation of International Scientific Advisory Boardfinance.yahoo.com - March 23 at 9:05 AMReShape Lifesciences® to Announce Financial Results for the Year Ended December 31, 2022, and Provide Corporate Updatefinance.yahoo.com - March 22 at 9:01 AMReShape Lifesciences(R) to Present at the Q2 Virtual Investor Summitmarketwatch.com - March 17 at 11:28 PMReShape Lifesciences® to Present at the Q2 Virtual Investor Summitfinance.yahoo.com - March 15 at 8:39 AMmarketbeat.com - February 8 at 12:25 PMReShape Lifesciences Shares Drop 60% After Public Offering Pricesmarketwatch.com - February 6 at 11:09 AMWhy ReShape Lifesciences (RSLS) Shares Are Plummetingmsn.com - February 6 at 11:09 AMReShape Lifesciences Announces Pricing of Upsized $10.2 Million Underwritten Public Offeringfinance.yahoo.com - February 6 at 11:09 AMReShape Lifesciences Announces Pricing of Upsized $10.2 Million Underwritten Public Offeringfinance.yahoo.com - February 6 at 11:09 AMReShape Lifesciences Stock More Than Doubles to $14.39marketwatch.com - February 4 at 12:15 AMmarketbeat.com - February 3 at 10:24 AMmarketbeat.com - February 3 at 10:14 AMmarketbeat.com - February 3 at 9:58 AMmarketbeat.com - February 3 at 9:52 AMmarketbeat.com - February 3 at 9:46 AMmarketbeat.com - February 3 at 9:39 AMmarketbeat.com - February 3 at 9:35 AMLooking Into Reshape Lifesciences's Recent Short Interestmsn.com - January 4 at 2:15 PMmarketbeat.com - January 3 at 1:20 PMmarketbeat.com - January 3 at 10:17 AMmarketbeat.com - January 3 at 10:10 AMmarketbeat.com - January 3 at 10:05 AMmarketbeat.com - January 3 at 9:45 AMmarketbeat.com - January 3 at 9:35 AMmarketbeat.com - December 29 at 11:07 AM Get ReShape Lifesciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RSLS and its competitors with MarketBeat's FREE daily newsletter. Email Address RSLS Media Mentions By Week RSLS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RSLS News Sentiment▼0.610.51▲Average Medical News Sentiment RSLS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RSLS Articles This Week▼21▲RSLS Articles Average Week Get ReShape Lifesciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RSLS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: INVO News DYNT News MOTS News RMED News INBS News NVIV News ICU News BJDX News PSTV News SINT News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:RSLS) was last updated on 9/24/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ReShape Lifesciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.